Loading...
Header Logo
Keywords
Last Name

Arthur W. Blackstock, Jr, M.D.

TitleChair
InstitutionWake Forest School of Medicine
DepartmentRadiation Oncology
Address
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionWake Forest School of Medicine
    DepartmentCancer Biology

    TitleChair
    InstitutionWake Forest School of Medicine
    DepartmentRadiation Oncology

    TitleProgram Director
    InstitutionWake Forest School of Medicine
    DepartmentComprehensive Cancer Center


    Collapse Research 
    Collapse research activities and funding
    R03CA075949     (BLACKSTOCK, ARTHUR W.)Aug 1, 1997 - Jan 31, 2000
    NIH/NCI
    PHASE II STUDY--RADIATION SENSITIZATION WITH GEMCITABINE
    Role: Principal Investigator
    R21CA084524     (BLACKSTOCK, ARTHUR W.)Jul 5, 2002 - Jun 30, 2005
    NIH/NCI
    Cytokines in radiation lung injury
    Role: Principal Investigator
    R01CA112593     (METHENY-BARLOW, LINDA J)Sep 30, 2004 - Apr 30, 2014
    NIH/NCI
    PPARs and Radiation-induced Brain Injury
    Role: Co-Principal Investigator
    T32CA113267     (BLACKSTOCK, ARTHUR W.)Aug 1, 2005 - Jun 30, 2015
    NIH/NCI
    Training Program in Translational Radiation Oncology
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jimenez H, Wang M, Zimmerman JW, Pennison MJ, Sharma S, Surratt T, Xu ZX, Brezovich I, Absher D, Myers RM, DeYoung B, Caudell DL, Chen D, Lo HW, Lin HK, Godwin DW, Olivier M, Ghanekar A, Chen K, Miller LD, Gong Y, Capstick M, D'Agostino RB, Munden R, Merle P, Barbault A, Blackstock AW, Bonkovsky HL, Yang GY, Jin G, Liu L, Zhang W, Watabe K, Blackman CF, Pasche BC. Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2?T-type voltage-gated calcium channels and Ca2+ influx. EBioMedicine. 2019 Jun; 44:209-224. PMID: 31160272.
      View in: PubMed
    2. Cramer CK, Alphonse-Sullivan N, Isom S, Metheny-Barlow LJ, Cummings TL, Page BR, Brown DR, Blackstock AW, Peiffer AM, Strowd RE, Rapp S, Lesser GJ, Shaw EG, Chan MD. Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial. J Cancer Res Clin Oncol. 2019 Feb; 145(2):337-344. PMID: 30417218.
      View in: PubMed
    3. Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED, D'Agostino RB, Petro RM, Blackstock W, Powell BL, Abraham E, Pasche B, Zhang W. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. J Hematol Oncol. 2017 05 04; 10(1):100. PMID: 28472989.
      View in: PubMed
    4. Okoukoni C, Randolph DM, McTyre ER, Kwok A, Weaver AA, Blackstock AW, Munley MT, Willey JS. Early dose-dependent cortical thinning of the femoral neck in anal cancer patients treated with pelvic radiation therapy. Bone. 2017 01; 94:84-89. PMID: 27780791.
      View in: PubMed
    5. Okoukoni C, Lynch SK, McTyre ER, Randolph DM, Weaver AA, Blackstock AW, Lally BE, Munley MT, Willey JS. A cortical thickness and radiation dose mapping approach identifies early thinning of ribs after stereotactic body radiation therapy. Radiother Oncol. 2016 06; 119(3):449-53. PMID: 27072937.
      View in: PubMed
    6. Kilburn JM, Lucas JT, Soike MH, Ayala-Peacock DN, Blackstock AW, Hinson WH, Munley MT, Petty WJ, Urbanic JJ. Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)? Cureus. 2016 Jan 23; 8(1):e466. PMID: 26929893.
      View in: PubMed
    7. Kilburn JM, Soike MH, Lucas JT, Ayala-Peacock D, Blackstock W, Isom S, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients. Pract Radiat Oncol. 2016 May-Jun; 6(3):e73-e80. PMID: 26725964.
      View in: PubMed
    8. Russo S, Blackstock AW, Herman JM, Abdel-Wahab M, Azad N, Das P, Goodman KA, Hong TS, Jabbour SK, Jones WE, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer. Am J Clin Oncol. 2015 Oct; 38(5):520-5. PMID: 26371522.
      View in: PubMed
    9. Daroui P, Jabbour SK, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Hong TS, Jones WE, Kaur H, Konski AA, Koong AC, Kumar R, Pawlik TM, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® Resectable Stomach Cancer. Oncology (Williston Park). 2015 Aug; 29(8):595-602, C3. PMID: 26281845.
      View in: PubMed
    10. Onyeuku NE, Ayala-Peacock DN, Russo SM, Blackstock AW. The multidisciplinary approach to the treatment of rectal cancer: 2015 update. Expert Rev Gastroenterol Hepatol. 2015 Apr; 9(4):507-17. PMID: 25431898.
      View in: PubMed
    11. Goodman KA, Milgrom SA, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Hong TS, Jabbour SK, Jones WE, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentation. Oncology (Williston Park). 2014 Oct; 28(10):867-71, 876, 878. PMID: 25323613.
      View in: PubMed
    12. Starr B, Davis S, Ayala-Peacock D, Blackstock WA, Levine EA. Reassessment of the role of enteral tube feedings for patients with esophageal cancer. Am Surg. 2014 Aug; 80(8):752-8. PMID: 25105392.
      View in: PubMed
    13. Gmeiner WH, Willingham MC, Bourland JD, Hatcher HC, Smith TL, D'Agostino RB, Blackstock W. F10 Inhibits Growth of PC3 Xenografts and Enhances the Effects of Radiation Therapy. J Clin Oncol Res. 2014 Jul-Aug; 2(4). PMID: 26020060.
      View in: PubMed
    14. Lucas JT, Kuremsky JG, Soike M, Hinson WW, Kearns WT, Hampton CJ, Blackstock AW, Urbanic J. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC). Lung Cancer. 2014 Jul; 85(1):59-65. PMID: 24813936.
      View in: PubMed
    15. Kilburn JM, Lester SC, Lucas JT, Soike MH, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer. J Thorac Oncol. 2014 Apr; 9(4):572-6. PMID: 24736084.
      View in: PubMed
    16. Kilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, Lovato JF, Miller AA, Petty WJ, Urbanic JJ. Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol. 2014 Mar; 110(3):505-10. PMID: 24444530.
      View in: PubMed
    17. Hong TS, Pretz JL, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Jabbour SK, Jones WE, Konski AA, Koong AC, Rodriguez-Bigas M, Small W, Thomas CR, Zook J, Suh WW. ACR Appropriateness Criteria®-Anal Cancer. Gastrointest Cancer Res. 2014 Jan; 7(1):4-14. PMID: 24558509.
      View in: PubMed
    18. Salama JK, Pang H, Bogart JA, Blackstock AW, Urbanic JJ, Hogson L, Crawford J, Vokes EE. Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. Lung Cancer. 2013 Dec; 82(3):436-40. PMID: 24396884.
      View in: PubMed
    19. Russo S, Blackstock AW. The 'watch-and-wait' approach for rectal cancer: are outcomes improved with more limited T stage and routine use of MRI for staging? Oncology (Williston Park). 2013 Oct; 27(10):976-7. PMID: 24367853.
      View in: PubMed
    20. Salama JK, Hodgson L, Pang H, Urbanic JJ, Blackstock AW, Schild SE, Crawford J, Bogart JA, Vokes EE. A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. J Thorac Oncol. 2013 Aug; 8(8):1043-9. PMID: 23715301.
      View in: PubMed
    21. Raftery L, Tepper JE, Goldberg RM, Blackstock AW, Aklilu M, Bernard SA, Ivanova A, Davies JM, O'Neil BH. A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinoma. Am J Clin Oncol. 2013 Jun; 36(3):250-3. PMID: 22547007.
      View in: PubMed
    22. Almeida C, Nagarajan D, Tian J, Leal SW, Wheeler K, Munley M, Blackstock W, Zhao W. The role of alveolar epithelium in radiation-induced lung injury. PLoS One. 2013; 8(1):e53628. PMID: 23326473.
      View in: PubMed
    23. Monjazeb AM, Blackstock AW. The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications. Semin Radiat Oncol. 2013 Jan; 23(1):60-73. PMID: 23207048.
      View in: PubMed
    24. Socinski MA, Stinchcombe TE, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Khandani A, Morris DE. Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial. J Clin Oncol. 2012 Nov 10; 30(32):3953-9. PMID: 23045594.
      View in: PubMed
    25. Kimple RJ, Russo S, Monjazeb A, Blackstock AW. The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer. Expert Rev Anticancer Ther. 2012 Apr; 12(4):469-80. PMID: 22500684.
      View in: PubMed
    26. Weaver KE, Danhauer SC, Tooze JA, Blackstock AW, Spangler J, Thomas L, Sutfin EL. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. Oncologist. 2012; 17(3):455-62. PMID: 22334454.
      View in: PubMed
    27. Konski AA, Suh WW, Herman JM, Blackstock AW, Hong TS, Poggi MM, Rodriguez-Bigas M, Small W, Thomas CR, Zook J. ACR Appropriateness Criteria®-Recurrent Rectal Cancer. Gastrointest Cancer Res. 2012 Jan; 5(1):3-12. PMID: 22574231.
      View in: PubMed
    28. Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J Natl Cancer Inst. 2011 Oct 19; 103(20):1498-506. PMID: 21997132.
      View in: PubMed
    29. Salama JK, Stinchcombe TE, Gu L, Wang X, Morano K, Bogart JA, Crawford JC, Socinski MA, Blackstock AW, Vokes EE. Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e269-74. PMID: 21477940.
      View in: PubMed
    30. Mamon HJ, Niedzwiecki D, Hollis D, Tan BR, Mayer RJ, Tepper JE, Goldberg RM, Blackstock AW, Fuchs CS. A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003. Cancer. 2011 Jun 15; 117(12):2620-8. PMID: 21656739.
      View in: PubMed
    31. Yang X, Walton W, Cook DN, Hua X, Tilley S, Haskell CA, Horuk R, Blackstock AW, Kirby SL. The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2011 Jul; 45(1):127-35. PMID: 20870892.
      View in: PubMed
    32. Center B, Petty WJ, Ayala D, Hinson WH, Lovato J, Capellari J, Oaks T, Miller AA, Blackstock AW. A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer. J Thorac Oncol. 2010 Jan; 5(1):69-74. PMID: 20035186.
      View in: PubMed
    Blackstock's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (163) concept(s)
    _
    Co-Authors Expand Description
    See all (47) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _